Aethlon Medical Granted Full Ethics Approval
Ethics Approval for Groundbreaking Gene-editing Treatment
Groundbreaking Gene-editing Treatment Granted Full Ethics Approval
Aethlon Medical Inc., a US-based medical therapeutic company, has received full ethics approval from the Bellberry Human Research Ethics Committee. This approval marks a significant milestone for the company's groundbreaking gene-editing treatment, which offers hope for patients with advanced diseases.
Comments